Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Journal of Clinical Gastroenterology
|
June 23, 2025
Medications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom
Gene Y Im, Amon Asgharpour, Elizabeth S Aby, et al.
Kidney International Reports
|
August 25, 2020
The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India
Narayan Prasad, Mansi Bhatt, Sanjay K Agarwal, et al.
World Journal of Virology
|
November 18, 2017
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results
Kian Bichoupan, Neeta Tandon, James F Crismale, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
August 26, 2024
Initial empirical antibiotic therapy in kidney transplant recipients with pyelonephritis: A global survey of current practice and opinions across 19 countries on six continents
Julien Coussement, Shyam B Bansal, Anne Scemla, et al.
The New England Journal of Medicine
|
February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Nature Reviews. Gastroenterology & Hepatology
|
September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Luis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
The New England Journal of Medicine
|
June 1, 2017
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Marc Bourlière, Stuart C Gordon, Steven L Flamm, et al.
Eclinicalmedicine
|
March 30, 2022
Management strategies and outcomes in renal transplant recipients recovering from COVID-19: A retrospective, multicentre, cohort study
Vivek B Kute, Deepak S Ray, Feroz Aziz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]
A Arora, H Bhaskarane, G Tansir, et al.
The Lancet Regional Health. Southeast Asia
|
June 12, 2025
Analysis of kidney and liver exchange transplantation in India (2000-2025): a multicentre, retrospective cohort study
Vivek B Kute, Himanshu V Patel, Subho Banerjee, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Journal of Clinical Gastroenterology
|
June 23, 2025
Medications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom
Gene Y Im, Amon Asgharpour, Elizabeth S Aby, et al.
Kidney International Reports
|
August 25, 2020
The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India
Narayan Prasad, Mansi Bhatt, Sanjay K Agarwal, et al.
World Journal of Virology
|
November 18, 2017
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results
Kian Bichoupan, Neeta Tandon, James F Crismale, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
August 26, 2024
Initial empirical antibiotic therapy in kidney transplant recipients with pyelonephritis: A global survey of current practice and opinions across 19 countries on six continents
Julien Coussement, Shyam B Bansal, Anne Scemla, et al.
The New England Journal of Medicine
|
February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Nature Reviews. Gastroenterology & Hepatology
|
September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Luis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
The New England Journal of Medicine
|
June 1, 2017
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Marc Bourlière, Stuart C Gordon, Steven L Flamm, et al.
Eclinicalmedicine
|
March 30, 2022
Management strategies and outcomes in renal transplant recipients recovering from COVID-19: A retrospective, multicentre, cohort study
Vivek B Kute, Deepak S Ray, Feroz Aziz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]
A Arora, H Bhaskarane, G Tansir, et al.
The Lancet Regional Health. Southeast Asia
|
June 12, 2025
Analysis of kidney and liver exchange transplantation in India (2000-2025): a multicentre, retrospective cohort study
Vivek B Kute, Himanshu V Patel, Subho Banerjee, et al.
Page
of 14